Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA

Vaccine

Volumn 28, Issue 36, 2010, Pages 5810-5816

  Torres Escobar, Ascención ^a   Juárez Rodríguez, María Dolores ^a   Branger, Christine G ^a   Curtiss, Roy ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Asd+; Codon optimized; PsaA antigen; PsaB chaperone protein; PsaC usher protein; Vaccine plasmid

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIVE VACCINE; PROTEIN PSAA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CODON; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; INDEL MUTATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN STABILITY; SALMONELLA TYPHIMURIUM; SURVIVAL; YERSINIA PESTIS; YERSINIOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; PLAGUE; PLAGUE VACCINE; SALMONELLA ENTERICA; VACCINES, ATTENUATED; YERSINIA PESTIS;

EID: 77955558220     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.070     Document Type: Article

References (55)

1. Perry R.D., Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin Microbiol Rev 1997, 10(1):35-66.
2. Hinnebusch B.J. The evolution of flea-borne transmission in Yersinia pestis. Curr Issues Mol Biol 2005, 7(2):197-212.
3. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Plague as a biological weapon: medical and public health management. JAMA 2000, 283(17):2281-2290.
4. Galimand M., Carniel E., Courvalin P. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother 2006, 50(10):3233-3236.
5. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., Titball R.W. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995, 13(16):1551-1556.
6. Meyer K.F. Effectiveness of live or killed plague vaccines in man. Bull World Health Organ 1970, 42(5):653-666.
7. Feodorova V.A., Corbel M.J. Prospects for new plague vaccines. Expert Rev Vaccines 2009, 8(12):1721-1738.
8. Lindler L.E., Tall B.D. Yersinia pestis pH 6 antigen forms fimbriae and is induced by intracellular association with macrophages. Mol Microbiol 1993, 8(2):311-324.
9. Cathelyn J.S., Crosby S.D., Lathem W.W., Goldman W.E., Miller V.L. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc Natl Acad Sci USA 2006, 103(36):13514-13519.
10. Chauvaux S., Rosso M.L., Frangeul L., Lacroix C., Labarre L., Schiavo A., et al. Transcriptome analysis of Yersinia pestis in human plasma: an approach for discovering bacterial genes involved in septicaemic plague. Microbiology 2007, 153(Pt 9):3112-3124.
11. Liu H., Wang H., Qiu J., Wang X., Guo Z., Qiu Y., et al. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host. J Basic Microbiol 2009, 49(1):92-99.
12. Ben-Efraim S., Aronson M., Bichowsky-Slomnicki L. New antigenic component of Pasteurella pestis formed under specified conditions of pH and temperature. J Bacteriol 1961, 81(5):704-714.
13. Lindler L.E., Klempner M.S., Straley S.C. Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun 1990, 58(8):2569-2577.
14. Han Y., Qiu J., Guo Z., Gao H., Song Y., Zhou D., et al. Comparative transcriptomics in Yersinia pestis: a global view of environmental modulation of gene expression. BMC Microbiol 2007, 7:96.
15. Torres-Escobar A., Juárez-Rodríguez M.D., Curtiss R. Biogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strain. FEMS Microbiol Lett 2010, 302(2):106-113.
16. Chen Z., Li B., Zhang J., Qin L., Zhou D., Han Y., et al. Quorum sensing affects virulence-associated proteins F1, LcrV, KatY and pH6 etc. of Yersinia pestis as revealed by protein microarray-based antibody profiling. Microbes Infect 2006, 8(9-10):2501-2508.
17. Zhou D., Qin L., Han Y., Qiu J., Chen Z., Li B., et al. Global analysis of iron assimilation and fur regulation in Yersinia pestis. FEMS Microbiol Lett 2006, 258(1):9-17.
18. Anisimov A.P., Bakhteeva I.V., Panfertsev E.A., Svetoch T.E., Kravchenko T.B., Platonov M.E., et al. The subcutaneous inoculation of pH 6 antigen mutants of Yersinia pestis does not affect virulence and immune response in mice. J Med Microbiol 2009, 58(Pt 1):26-36.
19. Huang X.Z., Lindler L.E. The pH 6 antigen is an antiphagocytic factor produced by Yersinia pestis independent of Yersinia outer proteins and capsule antigen. Infect Immun 2004, 72(12):7212-7219.
20. Makoveichuk E., Cherepanov P., Lundberg S., Forsberg A., Olivecrona G. pH 6 antigen of Yersinia pestis interacts with plasma lipoproteins and cell membranes. J Lipid Res 2003, 44:320-330.
21. Bichowsky-Slomnicki L., Ben-Efraim S. Biological activities in extracts of Pasteurella pestis and their relation to the " pH 6 antigen" J Bacteriol 1963, 86:101-111.
22. Zav'yalov V.P., Abramov V.M., Cherepanov P.G., Spirina G.V., Chernovskaya T.V., Vasiliev A.M., et al. pH 6 antigen (PsaA protein) of Yersinia pestis, a novel bacterial Fc-receptor. FEMS Immunol Med Microbiol 1996, 14(1):53-57.
23. Payne D., Tatham D., Williamson E.D., Titball R.W. The pH 6 antigen of Yersinia pestis binds to beta1-linked galactosyl residues in glycosphingolipids. Infect Immun 1998, 66(9):4545-4548.
24. Galván E.M., Chen H., Schifferli D.M. The Psa fimbriae of Yersinia pestis interact with phosphatidylcholine on alveolar epithelial cells and pulmonary surfactant. Infect Immun 2007, 75(3):1272-1279.
25. Li B., Jiang L., Song Q., Yang J., Chen Z., Guo Z., et al. Protein microarray for profiling antibody responses to Yersinia pestis live vaccine. Infect Immun 2005, 73(6):3734-3739.
26. Li B., Zhou L., Guo J., Wang X., Ni B., Ke Y., et al. High-throughput identification of new protective antigens from Yersinia pestis live vaccine by ELISPOT. Infect Immun 2009, 77(10):4356-4361.
27. Galván EM, Nair MK, Chen H, Del Piero F, Schifferli DM. A BSL-2 model of pneumonic plague and protection studies with F1 and Psa. Infect Immun. Published online ahead of print on May 24, 2010.
28. Cárdenas L., Clements J.D. Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens. Clin Microbiol Rev 1992, 5(3):328-342.
29. Curtiss R. Antigen delivery: development of live recombinant attenuated bacterial antigen and DNA vaccine delivery vector vaccine. Mucosal immunology 2005, 1009-1037. Academic Press, San Diego. 3rd ed. J. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee, L. Mayer (Eds.).
30. Amann E., Brosius J., Ptashne M. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 1983, 25(2-3):167-178.
31. Chatfield S.N., Charles I.G., Makoff A.J., Oxer M.D., Dougan G., Pickard D., et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine. Biotechnology (N Y) 1992, 10(8):888-892.
32. Everest P., Frankel G., Li J., Lund P., Chatfield S., Dougan G. Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells. FEMS Microbiol Lett 1995, 126(1):97-101.
33. Husseiny M.I., Hensel M. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins. Vaccine 2009, 27(28):3780-3787.
34. Matic J.N., Terry T.D., Van Bockel D., Maddocks T., Tinworth D., Jennings M.P., et al. Development of non-antibiotic-resistant, chromosomally based, constitutive and inducible expression systems for aroA-attenuated Salmonella enterica Serovar Typhimurium. Infect Immun 2009, 77(5):1817-1826.
35. Nakayama K., Kelly S.M., Curtiss R. Construction of an ASD+ expression-cloning vector: stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio/Technology 1988, 6:693-697.
36. Kong W., Wanda S.Y., Zhang X., Bollen W., Tinge S.A., Roland K.L., et al. Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containment. Proc Natl Acad Sci USA 2008, 105(27):9361-9366.
37. Gunn B.M., Wanda S.Y., Burshell D., Wang C., Curtiss R. Construction of recombinant attenuated Salmonella enterica Typhimurium vaccine (RASV) vector strains for safety in newborn and infant mice. Clin Vaccine Immunol 2010, 17(3):354-362.
38. Curtiss R., Wanda S.Y., Gunn B.M., Zhang X., Tinge S.A., Ananthnarayan V., et al. Salmonella enterica serovar Typhimurium strains with regulated delayed attenuation in vivo. Infect Immun 2009, 77(3):1071-1082.
39. Bollen W.S., Gunn B.M., Mo H., Lay M.K., Curtiss R. Presence of wild-type and attenuated Salmonella enterica strains in brain tissues following inoculation of mice by different routes. Infect Immun 2008, 76(7):3268-3272.
40. Li Y., Wang S., Scarpellini G., Gunn B., Xin W., Wanda S.Y., et al. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc Natl Acad Sci USA 2009, 106(2):593-598.
41. Shi H., Wang S., Roland K.L., Gunn B.M., Curtiss R. Immunogenicity of a live recombinant Salmonella vaccine expressing pspA in neonates and infant mice born from naive and immunized mothers. Clin Vaccine Immunol 2010, 17(3):363-371.
42. Bertani G. Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol 1951, 62:293-300.
43. Kang H.Y., Srinivasan J., Curtiss R. Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar Typhimurium vaccine. Infect Immun 2002, 70(4):1739-1749.
44. Matsuyama S., Inokuchi K., Mizushima S. Promoter exchange between ompF and ompC, genes for osmoregulated major outer membrane proteins of Escherichia coli K-12. J Bacteriol 1984, 158(3):1041-1047.
45. Curtiss R. Chromosomal aberrations associated with mutations to bacteriophage resistance in Escherichia coli. J Bacteriol 1965, 89(1):28-40.
46. Branger C.G., Fetherston J.D., Perry R.D., Curtiss R. Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella Typhimurium elicits a protective immune response against plague. Adv Exp Med Biol 2007, 603:387-399.
47. Getahun A., Dahlström J., Wernersson S., Heyman B. IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors. J Immunol 2004, 172(9):5269-5276.
48. Iankov I.D., Petrov D.P., Mladenov I.V., Haralambieva I.H., Ivanova R., Sechanova L., et al. Monoclonal antibodies of IgA isotype specific for lipopolysaccharide of Salmonella enteritidis: production, purification, characterization and application as serotyping reagents. FEMS Microbiol Lett 2001, 196(2):215-221.
49. Sirard J.C., Niedergang F., Kraehenbuhl J.P. Live attenuated Salmonella: a paradigm of mucosal vaccines. Immunol Rev 1999, 171:5-22.
50. Srinivasan J.A., Nayak A., Curtiss R., Rubino S. Effect of the route of immunization using recombinant Salmonella on mucosal and humoral immune responses. Vaccines 95 1995, 273-280. Cold Spring Harbor Laboratory Press, Plainview, NY. R.M. Chanock, F. Brown, H.S. Ginsberg, E. Norrby (Eds.).
51. Hopkins S., Kraehenbuhl J.P., Schödel F., Potts A., Peterson D., de Grandi P., et al. A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization. Infect Immun 1995, 63(9):3279-3286.
52. Torres-Escobar A., Juárez-Rodríguez M.D., Gunn B.M., Branger C.G., Tinge S.A., Curtiss R. Fine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in mice. Infect Immun 2010, 78(6):2529-2543.
53. Titball R.W., Williamson E.D. Vaccination against bubonic and pneumonic plague. Vaccine 2001, 19(30):4175-4184.
54. Felek S., Krukonis E.S. Three Yersinia pestis adhesins play a role in Yop delivery to eukaryotic cells and virulence. Abstract B-142. 109th General Meeting. American Society for Microbiology 2009.
55. Liu F., Chen H., Galván E.M., Lasaro M.A., Schifferli D.M. Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells. Infect Immun 2006, 74(10):5636-5644.